(Q38558150)

4 September 2017

1 reference

title

Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections: A Systematic Review (English)

1 reference

4 September 2017

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228937%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

author name string

Michelle L Bryson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228937%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

language of work or name

English

0 references

publication date

30 July 2015

1 reference

Annals of Pharmacotherapy

4 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228937%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228937%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

page(s)

1125-1135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228937%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228937%20AND%20SRC:MED&resulttype=core&format=json

Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness

15 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Comparative inhibition of influenza and parainfluenza virus replication by ribavirin in MDCK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Effects of ribavirin on respiratory syncytial virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028015597449

21 January 2018

Identifiers

DOI

10.1177/1060028015597449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228937%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

1 reference